Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Elanco Animal Health Incorporated    ELAN

ELANCO ANIMAL HEALTH INCORPORATED

(ELAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Elanco Animal Health Incorporated : Releases Healthy Purpose™ 2030 Sustainability Commitments to Improve Health of Animals, People and Planet

10/27/2020 | 07:11am EST

New Protein, Planet and Pet Pledges, aligned to United Nations Sustainable Development Goals (SDGs), aim to provide improved access to nutritious protein, reduce the company’s and customers’ footprint on the planet, and help support more healthy pets that in turn support people’s wellbeing.

Elanco Animal Health Incorporated (NYSE: ELAN) today announced its first sustainability commitments, just two years after becoming an independent company. The decade-long commitments support the SDGs, address societal challenges and underscore Elanco’s role in improving the health of animals, which also improves the health of people and the planet.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005347/en/

Elanco's Healthy Purpose 2030 sustainability pledges are powered by purposeful people, innovation and access. (Graphic: Business Wire)

Elanco's Healthy Purpose 2030 sustainability pledges are powered by purposeful people, innovation and access. (Graphic: Business Wire)

Today, the company is issuing three Healthy Purpose Pledges to drive sustainable change by 2030, including:

  • Protein Pledge: Create more resilient food systems by enabling 57 million more people to access their annual nutritious protein needs.
  • Planet Pledge: Remove 21 million tons of emissions from customers’ farms while reducing the company’s own impact on the planet.
  • Pet Pledge: Improve the world’s wellbeing by helping at least 100 million healthy pets help people.

"Business can be a unique force for good, and at Elanco, we believe we have the opportunity and responsibility to help tackle key societal challenges," said Jeff Simmons, president and CEO at Elanco. "Elanco's Healthy Purpose sustainability commitments, the first of its kind in the animal health industry, advances the world’s wellbeing while supporting and strengthening our own business. It all starts with a healthy, strong enterprise driven by the growth, innovation and margin expansion agenda we are executing against. Through these efforts, Elanco is focused on creating value for our customers, employees, shareholders and society as a whole.”

With millions in the world unable to access affordable, nutritious protein, the Elanco Protein Pledge is an active commitment to improve the efficiency and sustainability of every farmer the company works with, improve the health and welfare of 3 billion farm animals and support and enhance agricultural productivity and income of 250,000 dairy and poultry smallholder farmers.

The natural environment needs protection and Elanco can help reduce impacts and develop solutions to support customers, while minimizing the company’s own impact. Elanco’s Planet Pledge is a commitment to be customers’ lead partner on the journey toward net zero emissions on their farms, grow the product portfolio with environmental benefits and accelerate toward sustainable packaging while achieving 100% renewable sources of electricity across the company’s operations.

Ultimately, the combination of Elanco’s Protein and Planet Pledges will help the company drive a decrease in the global emissions intensity of animal protein by 2%, compared to business-as-usual 2030.

The connection between animals and humans is powerful. Pets can be a prescription on four legs to improve physical, social and emotional health. Elanco’s Pet Pledge will help 40 million more pets receive better care through the company's work with veterinarians and pet owners, innovate by delivering a constant flow of new medicines and health products for pets, and help the world understand and experience the benefits of pets on wellbeing.

“Three clear reasons will help us achieve our Healthy Purpose Pledges – the Elanco Differentiators: People, Access, and Innovation,” said Simmons. “With the industry’s most passionate, highly-engaged people, innovation created with purpose, and access to 19 species of animals in nearly 100 countries, Elanco has the ability to address our customers’ and society’s greatest needs. We look forward to partnering with, and learning from, our customers and stakeholders who share our drive to achieve these goals.”

Elanco believes in creating a culture of people with purpose, an inclusive safe harbor where employees can bring their whole self to work and have the opportunity for personal growth, defining their own purpose or “why” and creating their own personal standard operating procedure to support wellbeing.

The company is committed to tracking performance and engaging with stakeholders through ongoing dialogue, input, and regular performance disclosure. This commitment includes learning from experts and partners to ensure the approach evolves in line with best practices and the world’s needs. Watch Elanco’s Healthy Purpose Pledges and its measures come to life on Elanco.com and through Elanco’s social channels.

ABOUT ELANCO

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ Sustainability/ESG framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

Forward Looking Statements

This press release may include certain statements concerning expectations for the future that are forward-looking statements as defined by federal securities law. Such forward-looking statements are subject to a variety of known and unknown risks, uncertainties, and other factors that are difficult to predict and many of which are beyond management’s control. These risks and assumptions are described in Elanco’s annual reports on Form 10-K and other reports that are available from the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s view only as of the date made. We undertake no obligation to update any forward-looking statement, except as otherwise required by law.


© Business Wire 2020
All news about ELANCO ANIMAL HEALTH INCORPORATED
01/21Buttigieg Pledges to Support Biden's $2 Trillion Infrastructure Plan
DJ
01/19ELANCO ANIMAL HEALTH INCORPORATED : Dr. Marijn Dekkers Named Chairman of AgBiome..
PR
01/11ELANCO ANIMAL HEALTH INC : Other Events, Financial Statements and Exhibits (form..
AQ
01/11ELANCO ANIMAL HEALTH INCORPORATED : Begins Next Phase of Integration Post-Bayer ..
BU
2020ELANCO ANIMAL HEALTH INCORPORATED : to Participate in the 39th Annual J.P. Morga..
BU
2020ELANCO ANIMAL HEALTH INC : Other Events (form 8-K)
AQ
2020ELANCO ANIMAL HEALTH INCORPORATED : Lifts Q4 Revenue Outlook, Provides FY2021 Gu..
MT
2020ELANCO ANIMAL HEALTH INC : Regulation FD Disclosure, Financial Statements and Ex..
AQ
2020ELANCO ANIMAL HEALTH INCORPORATED : Hosts Investor Day, Demonstrating Inflection..
BU
2020ELANCO ANIMAL HEALTH INC : Change in Directors or Principal Officers, Other Even..
AQ
More news
Financials (USD)
Sales 2020 3 185 M - -
Net income 2020 -319 M - -
Net Debt 2020 5 599 M - -
P/E ratio 2020 -42,1x
Yield 2020 -
Capitalization 14 375 M 14 375 M -
EV / Sales 2020 6,27x
EV / Sales 2021 4,33x
Nbr of Employees 6 080
Free-Float 95,8%
Chart ELANCO ANIMAL HEALTH INCORPORATED
Duration : Period :
Elanco Animal Health Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELANCO ANIMAL HEALTH INCORPORATED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 33,30 $
Last Close Price 30,46 $
Spread / Highest target 34,6%
Spread / Average Target 9,32%
Spread / Lowest Target -17,9%
EPS Revisions
Managers and Directors
NameTitle
Jeffrey N. Simmons President, Chief Executive Officer & Director
R. David Hoover Independent Chairman
Todd S. Young CFO & EVP-Corporate Governance & Strategy
Sarena S. Lin Executive VP-Transformation & Technology
Christopher Keeley Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ELANCO ANIMAL HEALTH INCORPORATED-0.68%14 375
ZOETIS-1.31%77 625
DECHRA PHARMACEUTICALS PLC6.43%5 426
JINYU BIO-TECHNOLOGY CO., LTD.0.53%3 649
VIRBAC-7.56%2 259
VÉTOQUINOL SA6.94%1 288